Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Chalazion × Sevoflurane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Colonic Neoplasms 3 Respiratory Aspiration 2 Postoperative Complications 2 Brain Neoplasms 2 Uterine Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Quality of Recovery 1 Prostatic Neoplasms 1 Postoperative Cognitive Complications 1 Pituitary Neoplasms 1 Pain, Postoperative 1 Neoplastic Cells, Circulating 1 Myofibroma 1 Melanoma 1 Lymphoma, Follicular 1 Liver Functions Tests 1 Intraoral Tumor 1 Hypoxia 1 Female Breast Cancer 1 Endoplasmic Reticulum Stress 1 Delirium 1 Cough 1 Chalazion 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Tumor Adult 1

Interventions

Conservative Treatment 3 Probiotics 2 Sevoflurane 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07450495 2026-03-04

SEVO-PED

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Phase NA Recruiting

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡